-
1
Tumor-derived EVs can migrate from blood to urine.
-
2
The kidney glomerulus plays a key role in this transfer.
-
3
EVs contain proteins and nucleic acids that reflect tumor characteristics.
-
4
The study used engineered cancer cells in mouse models.
-
5
Findings may improve urine-based cancer diagnostics.
-
6
Glomerular processing may enrich EV populations in urine.
-
7
Further research needed to assess this across tumor types.
Original Source(s)
Related Content
Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
One in 10 patients who present to the emergency room (ER) with visible hematuria die within 3 months, new research from the United Kingdom has indicated. The WASHOUT study found that a scan administer...
March 18, 2026
-
4 min
New AACR President-Elect and Board Members Announced
The American Association for Cancer Research (AACR) has announced that Robert H. Vonderheide, MD, DPhil, has been named the 2026–2027 AACR President-elect. Dr. Vonderheide is an renowned cancer immuno...
March 18, 2026
-
6 min
Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer
The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...
by Jo Cavallo
March 18, 2026
-
5 min